NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/08/2025
Voltar para busca
Dado oficial do USPTO
ONCOSWEEP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOSWEEP
ST13
US500000097665270Classe
1, 5, 42, 44
Pedido
97665270
Registro
7892446
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
07/11/2022
Data de registro
12/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/08/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
19/12/2024
Primeiro uso no comércio
19/12/2024
Código do desenho
4
Tipo de titular
03
Localização do titular
Zhubei, Hsinchu County, TW
Examinador
HOWELL, MATTHEW P
Unidade examinadora
N50
Localização atual
TMO LAW OFFICE 123
Titulares e representantes
Titulares
Pharus Taiwan, Inc.
Representantes
Chinhwei Chen JIANQ CHYUN INTELLECTUAL PROPERTY OFFICE
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Bacterial preparations other than for medical and veterinary use; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; Industrial chemicals; Biological preparations for use in industry and scienceother than for medical or veterinary purposes; Chemical preparations for scientific purposesother than for medical or veterinary use; Cultures of microorganismsother than for medical and veterinary use; Chemicals for use in science; Nucleic acid amplification reagents other than for medical and veterinary purposes; Reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) for use in scientific researchother than for medical or veterinary purposes; Chemical reagents for genetic identity testing for non-medical purposes; Chemical reagents for use in diagnostic testsother than for medical or veterinary use; Chemical reagents for use in analytical testsother than for medical or veterinary use; Chemical reagents for non-medical purposes; Enzymes for detecting proteinsother than for medical usefor use in the early detection of cancers; Biochemical testing reagents other than for medical purposes; Chemical reagents for laboratory useother than for medical or veterinary use; Chemical reagents for use in genetic researchother than for medical or veterinary purposes; Testing reagents for liquid biopsy for scientific useother than for medical or veterinary use; Kits comprising chemicals for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and biological and biochemical sample materialin particular comprising chemicals for reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplificationsequencing and analysisnot for medical purposesfor laboratory or research use; Clinical diagnostic reagents for scientific or research use; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; Chemicalbiochemical and biotechnological products for commercial and scientific usebuffer solutions for use in analytical chemistrynucleic acids for laboratory usenucleic acid derivatives and proteins for chemical analysis; Clinical diagnostic reagents for medical use
Classe 5
Enzyme preparations for medical purposes; Bacterial preparations for medical purposes; medical diagnostic assays for testing of bodily fluids and tissue in the detectionmonitoringprediction of disease or other conditionsdisease stateshormone leveldrug leveldrug responseorgan function effectivenessclinical response; Reagents for use in diagnostic tests for medical purposes; Diagnostic biomarker reagents for medical purposes; Reagent paper for medical purposes; Chemical test reagents for medical use; chemical reagents for medical purposesdiagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; Reagents for use in medical genetic testing; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical purposes
Classe 42
Research and development for biotechnological and medical research purposes in the field of cancer early detection; Biochemical research and analysis; Advisory services relating to the custom design and development of chemical reagents; Scientific research in the nature of conducting clinical trials for others for pharmaceutical products; Providing information about the results of clinical trials for pharmaceutical products; Scientific research in the nature of conducting clinical trials for others; science and technological servicesresearch in the field of medicinemedical and biological technologies; Scientific laboratory services; Scientific research in the field of genetics; Scientific research relating to genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research; Product quality testing; Research and development of new products for others; Chemical research; Chemical analysis; Genetic testing for scientific research purposes; Scientific research in the field of genetics and genetic engineering; Rental of laboratory apparatus and instruments; Computer software consultancy; Maintenance of computer software; Monitoring of computer systems by remote access to protect data and information from unauthorized access; Medical laboratory services for the analysis of samples taken from patients
Classe 44
Medical treatment services; Medical health assessment services; Health counseling; Provision of medical treatment services; Health assessment services; Medical examination services; Medical counseling; Medical equipment rental; Medical testing for diagnostic or treatment purposes; Providing medical information; Advisory services pertaining to pharmacology; Health care; Physical examination services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening; Hospital services; Medical and health clinic services relating to DNAgenetics and genetic testing; Genetic testing for medical purposes; Genetic counseling; Medical services; Genetic testing for medical diagnostic or medical treatment purposes; Remote monitoring of medical data for medical diagnosis and treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
19/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
14/05/2025
IUAF
USE AMENDMENT FILED
13/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/02/2025
EX2G
SOU EXTENSION 2 GRANTED
05/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/02/2025
EXT2
SOU EXTENSION 2 FILED
17/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
17/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/04/2024
EX1G
SOU EXTENSION 1 GRANTED
24/04/2024
EXT1
SOU EXTENSION 1 FILED
24/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
24/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2023
PUBO
PUBLISHED FOR OPPOSITION
03/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/08/2023
GNRT
NON-FINAL ACTION E-MAILED
22/08/2023
CNRT
NON-FINAL ACTION WRITTEN
22/08/2023
DOCK
ASSIGNED TO EXAMINER
22/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/11/2022
NWAP
NEW APPLICATION ENTERED
10/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOSWEEP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.